MIGHTY: An Exercise Intervention for Prostate Cancer Patients Receiving Androgen Deprivation Therapy

Sponsor
Georgetown University (Other)
Overall Status
Completed
CT.gov ID
NCT02248350
Collaborator
American Cancer Society, Inc. (Other)
19
1
2
36
0.5

Study Details

Study Description

Brief Summary

This main purpose of this study is to examine the effects of an exercise intervention to counteract adverse side effects related to Androgen Deprivation Therapy (ADT) in prostate cancer patients. Specifically, a supervised and home-based exercise program will be used to assess its impact on clinical and behavioral variables related to ADT in prostate cancer patients.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Supervised and Home Based Exercise
  • Behavioral: Stretching Control Group
N/A

Detailed Description

This study will assess the feasibility of an exercise intervention to counteract adverse side effects related to ADT in prostate cancer (PCa) patients. Specifically, we will use an exercise intervention and assess its impact on bone mass density, Body Mass Index (BMI), hip/waist circumference levels, biomarkers (i.e., glucose, lipids), step count, grip strength, and health-related quality of life (HRQOL) using the Patient Reported Outcomes Measurement Information System (PROMIS®). In this 8-week two-arm randomized clinical trial, 40 PCa patients receiving ADT will be randomly assigned to an exercise (n=20) or a stretching control group (n=20) with a follow-up at 8-weeks.

Study Design

Study Type:
Interventional
Actual Enrollment :
19 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Supportive Care
Official Title:
An Exercise Intervention to Mitigate Side-Effects Related to Androgen Deprivation Therapy Among Prostate Cancer Survivors.
Study Start Date :
Sep 1, 2014
Actual Primary Completion Date :
Sep 1, 2017
Actual Study Completion Date :
Sep 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Exercise Group

8-weeks of supervised and home based exercise intervention, 3 times a week, 50-minutes a session for a total of 150/minutes a week

Behavioral: Supervised and Home Based Exercise
Participants will come to our community based research office for up to 50 min/session, 3-days/week of supervised exercise for 8-weeks. The exercise intensity will be tailored between 60-80% of their VO2max, as determined during baseline testing and with a rating of perceived exertion (RPE) of 11-14 on the 20-point scale.

Active Comparator: Stretching Control group

Informational booklet containing stretching exercises (20-minutes a day)

Behavioral: Stretching Control Group
Participants randomized into the control group will be provided an informational booklet with stretching techniques and exercises and will be asked to stretch at least 20-minutes a day for the duration of the study.

Outcome Measures

Primary Outcome Measures

  1. Bone Mineral Density [8-weeks]

    BMD will be measured by a DXA scan

Secondary Outcome Measures

  1. Physical Fitness [8-weeks]

    . The Bruce treadmill protocol will be used to examine VO2max using a ParvoMedics TrueOne 2400 metabolic cart

  2. Muscle strength [8-weeks]

    Grip strength will be measured in a standardized way (three times in each arm) using a Jamar Dynamometer

  3. Step Count [8-weeks]

    The Fit Bit reliably measures daily steps taken, distance walked, calories burned, and overall activity level.

  4. Quality of Life (HRQOL) [8-weeks]

    The 10-item PROMIS® Global Health Scale will be used to assess key HRQOL domains including pain, fatigue, mental health, physical health, social health, and overall health

  5. Hip/Waist Circumference [8-weeks]

    Anthropometric measures

  6. Body Mass Index (BMI) [8-weeks]

    BMI will be measured according to height and weight

  7. Glucose/Lipid levels [8-weeks]

    A fasting finger stick sample of blood (35 μl) will be assessed for immediate analysis of lipid panel (i.e., total cholesterol, HDL cholesterol, LDL cholesterol, VLDL cholesterol, triglycerides) and fasting glucose

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 70 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • (1) Caucasian or African-American/Black men; (2) histologically confirmed non-metastatic PCa; (3) receiving ADT treatment for 9-months or less upon recruitment (and continue to receive treatment during the duration of the study); (4) 40 to 75 years old; (5) sedentary defined as <60 minutes of recreation or work requiring modest PA/week; (6) ability to perform the level of physical activity assessed by the Physical Activity Readiness Questionnaire (PAR-Q); (6) has access to a smartphone or computer with internet capabilities
Exclusion Criteria:
  • (1) severe cardiac disease; (2) recent myocardial infarction; (3) treated for any other cancer; (4) any physical, psychological illness, and/or medical problems that restricted them from exercise; (5) and not willing or able to follow procedures specified by the study and/or instructions of the researcher.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Office of Minority Health and Health Disparities Research Washington District of Columbia United States 20003

Sponsors and Collaborators

  • Georgetown University
  • American Cancer Society, Inc.

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Georgetown University
ClinicalTrials.gov Identifier:
NCT02248350
Other Study ID Numbers:
  • Georgetown_University_MC
First Posted:
Sep 25, 2014
Last Update Posted:
Feb 15, 2018
Last Verified:
Jul 1, 2016
Keywords provided by Georgetown University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 15, 2018